Pancreatic cancer is lethal and notoriously difficult to treat, therefore, there is an urgent need to develop new therapeutic and diagnostic modalities. This Review discusses the agents that have been developed to target the pathways and processes involved in pancreatic tumorigenesis, and reviews the results of laboratory and clinical trials of these agents. Future therapeutic targets are also discussed.
- Han H. Wong
- Nicholas R. Lemoine